» Articles » PMID: 27656437

Antifungal Activity of Cinnamon Oil and Olive Oil Against Candida Spp. Isolated from Blood Stream Infections

Overview
Specialty General Medicine
Date 2016 Sep 23
PMID 27656437
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Recently non-albicans Candida has emerged as a major cause of morbidity and mortality in blood stream infections. Some species of the Candida are becoming increasingly resistant to first line and second line antifungals such as echinocandins and fluconazole. In view of increasing global antifungal resistance, role of alternative and better antifungals like natural plant products need to be explored. Essential oils are known to exhibit antimicrobial activity against various fungi. Hence, we evaluated the efficacy of cinnamon oil and olive oil against Candida spp.

Aim: To evaluate the invitro antifungal activity of olive oil and cinnamon oil against blood stream Candida isolates.

Materials And Methods: The present prospective observational study was conducted in the Department of Microbiology at a tertiary care teaching hospital during one year June 2011-July 2012. Blood samples were collected from 1376 patients clinically suspected to have fungal septicaemia, out of which 100 (7.2%) Candida isolates obtained, were speciated by conventional methods. Antifungal susceptibility testing of all the isolates was done against fluconazole, voriconazole as per NCCL (M27-A2) and against olive oil and cinnamon oil by agar well diffusion method.

Results: Prevalence of Candidemia was 7.26%. C. albicans (85.3%) and C. parapsilosis (85.7%) were most sensitive to fluconazole followed by C. tropicalis (67.4%). All isolates were 100% sensitive to voriconazole. Both oils were found to be effective against nearly 50% of the Candida isolates. About 55.5% of fluconazole resistant C. krusei strains were sensitive to olive and cinnamon oil.

Conclusion: Fluconazole resistant non-albicans Candida has emerged as major cause of Candidemia. Cinnamon and olive oil show marked sensitivity against albicans and non-albicans spp.

Citing Articles

Augmentation of antifungal activity of fluconazole using a clove oil nanoemulgel formulation optimized by factorial randomized D-optimal design.

Badr-Eldin S, Aldawsari H, Kotta S, Elfaky M 3 Biotech. 2024; 14(11):270.

PMID: 39430772 PMC: 11489362. DOI: 10.1007/s13205-024-04116-1.


Mechanism and bioinformatics analysis of the effect of berberine-enhanced fluconazole against drug-resistant Candida albicans.

Wu S, Jia W, Lu Y, Jiang H, Huang C, Tang S BMC Microbiol. 2024; 24(1):196.

PMID: 38849761 PMC: 11157861. DOI: 10.1186/s12866-024-03334-0.


Natural Substances as Valuable Alternative for Improving Conventional Antifungal Chemotherapy: Lights and Shadows.

Arguelles J, Sanchez-Fresneda R, Arguelles A, Solano F J Fungi (Basel). 2024; 10(5).

PMID: 38786689 PMC: 11122340. DOI: 10.3390/jof10050334.


Development and Evaluation of Essential Oil-Based Nanoemulgel Formulation for the Treatment of Oral Bacterial Infections.

Ullah N, Amin A, Farid A, Selim S, Rashid S, Imran Aziz M Gels. 2023; 9(3).

PMID: 36975701 PMC: 10048686. DOI: 10.3390/gels9030252.


Antifungal Potential of Some Herb Decoctions and Essential Oils on Species.

Noites A, Araujo B, Machado J, Pinto E Healthcare (Basel). 2022; 10(10).

PMID: 36292266 PMC: 9601325. DOI: 10.3390/healthcare10101820.


References
1.
Oberoi J, Wattal C, Goel N, Raveendran R, Datta S, Prasad K . Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India. Indian J Med Res. 2013; 136(6):997-1003. PMC: 3612330. View

2.
Amrutkar P, Rege M, Chen H, Larocco M, Gentry L, Garey K . Comparison of risk factors for candidemia versus bacteremia in hospitalized patients. Infection. 2006; 34(6):322-7. DOI: 10.1007/s15010-006-5677-4. View

3.
Alves T, Silva A, Brandao M, Grandi T, Smania E, Smania Junior A . Biological screening of Brazilian medicinal plants. Mem Inst Oswaldo Cruz. 2000; 95(3):367-73. DOI: 10.1590/s0074-02762000000300012. View

4.
Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J . Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis. 2004; 38(3):311-20. DOI: 10.1086/380637. View

5.
Nieto-Rodriguez J, Kusne S, Manez R, Irish W, Linden P, Magnone M . Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg. 1996; 223(1):70-6. PMC: 1235065. DOI: 10.1097/00000658-199601000-00010. View